Durham University
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1832-01-01
- Employees
- 4.2K
- Market Cap
- -
- Website
- https://dur.ac.uk
Clinical Trials
12
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Visual Perception Difficulties After Stroke
- Conditions
- StrokeVisual Perception
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Durham University
- Target Recruit Count
- 200
- Registration Number
- NCT05981482
- Locations
- 🇬🇧
Abingdon Community Hospital, Abingdon, United Kingdom
🇬🇧Bishop Auckland Hospital, Bishop Auckland, United Kingdom
🇬🇧Queen Elizabeth Hospital, Gateshead, United Kingdom
Sex Differences in Muscle Damage Following Resistance Exercise at Low or High Intensity
- Conditions
- Muscle Damage
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Durham University
- Target Recruit Count
- 40
- Registration Number
- NCT05111054
- Locations
- 🇬🇧
Durham University, The Graham Sports Centre, Durham, County Durham, United Kingdom
Sex Differences in Muscle Damage Following Resistance Exercise With or Without Milk Protein Ingestion
- Conditions
- Muscle Damage
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- Durham University
- Target Recruit Count
- 40
- Registration Number
- NCT04986150
- Locations
- 🇬🇧
Durham University, Sports and Wellbeing Park, Durham, United Kingdom
Terahertz Metamaterials for Tumour Marker Concentration Identification
- Conditions
- Malignant Tumour
- First Posted Date
- 2019-10-14
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Durham University
- Target Recruit Count
- 90
- Registration Number
- NCT04125524
- Locations
- 🇬🇧
Department of Engineering Durham University, Durham, United Kingdom
News
Magnitude Biosciences Secures £700K to Advance High-Throughput Drug Discovery Platform
Durham University spin-out Magnitude Biosciences raised £700,000 through investors and grants to develop its WormGazer high-throughput screening platform for age-related conditions and difficult-to-treat diseases.